HC: Skip to main content

Go to the home page

Loading...

Search

Company
Innovation
Pipeline
- Pipeline
- Clinical Development
- Regulatory strategy
- O-12-M1
- HORIZON
- OCEAN
- ANCHOR
- BRIDGE
- PORT
- Early Access Program
Investors
Sustainability
Media
Career
Contact
- Contact
- Global Headquarters

Change Region
- Global
- United States
  
  You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com
Change Language
- English
- Swedish
Loading...
Search

Change Region

Global
United States

You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com

Change Language

English
Swedish

Investors
Investor presentations
Jakob Lindberg interviewed in DI Börsmorgon

Investor presentations

Jakob Lindberg interviewed in DI Börsmorgon

January 25, 2018

Oncopeptides CEO Jakob Lindberg is being interviewed in DI Börsmorgon, January 25, 2018.

Links

Our history
Pipeline

Press releases
Investor Presentations
The share

Company in brief
Culture & values

Contact
Global Headquarters

About cookies
Privacy Policy
Privacy Policy - Pharmacovigilance
Terms of use
Glossary

© 2022 Oncopeptides AB (publ). All rights reserved. Registration number: 556596-6438